Differentiating HIV-associated lymphomas that exhibit plasmacellular differentiation

HIV and AIDS Review

Volumn 4, Issue 3, 2005, Pages 43-49

  Jaffar, Syed A ^a   Pihan, German ^b   Dezube, Bruce J ^b   Pantanowitz, Liron ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AIDS; EBV; HHV8; HIV; Lymphoma; Plasma cell

Indexed keywords

ANTIRETROVIRUS AGENT; CD20 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; KI 67 ANTIGEN; PARAPROTEIN; PROTEIN BCL 6; PROTEIN P53; SYNDECAN 1;

B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLASTIC LYMPHOMA; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR BIOLOGY; MOUTH CANCER; PHENOTYPE; PLASMA CELL; PRIMARY EFFUSION LYMPHOMA; REVIEW; SOLID TUMOR; SUPERINFECTION;

EID: 27744554301     PISSN: 17301270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Raphael M, Borisch B, Jaffe ES. Lymphomas associated with infection by the human immunodeficiency virus (HIV). In: Jaffe ES, Harris NL, Stein H, and Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001: 260-263.
2. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 2003; 17:785-820.
3. Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol 2002; 33: 392-404.
4. Carbone A, Gloghini A, Canzonieri V, Tirelli U, Gaidano G. AIDS-related extranodal non-Hodgkin's lymphomas with plasma cell differentiation. Blood 1997; 90: 1337-1338.
5. Aboulafia DM, Pantanowitz L, Dezube BJ. AIDS-related non-Hodgkin's lymphoma: still a problem in the era of highly active antiretroviral therapy. AIDS Reader. 2004; 14: 605-617.
6. Pantanowitz L, Dezube BJ. AIDS-related cancer; new entities, emerging targets, and novel tactics. Abstracts in Hematology and Oncology. 2005; 8: 20-30.
7. Pantanowitz L, Wu Z, Dezube BJ, Pihan G. Human Herpesvirus 8 (HHV8)-associated extracavitary-based lymphoma of the anorectum. Clinical Lymphoma 2005; In Press.
8. Carbone A, Gaidano G, Gloghini A, et al. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 1998; 91: 747-755.
9. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001; 97: 744-751.
10. Raphael MM, Audouin J, Lamine M, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors. Am J Clin Pathol 1994; 101: 775-782.
11. Engels EA, Rosenberg PS, Frisch M, Goedert JJ. Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma. Br J Cancer 2001; 85: 1298-1303.
12. Engels EA, Pittaluga S, Whitby D, et al. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus. Mod Pathol 2003; 16: 424-429.
13. Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005; 2005; 19: 851-5.
14. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89: 1413-1420.
15. Carbone A, Gaidano G, Gloghini A, Ferlito A, Rinaldo A, Stein H. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol 1999; 108: 95-99.
16. Gaidano G, Cerri M, Capello D, et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol 2002; 119: 622-628.
17. Lin Y, Rodrigues GD, Turner JF, Vasef MA. Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med 2001; 125: 282-285.
18. Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MM. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 2002; 43: 425-426.
19. Chetty R, Hlatswayo N, Muc R, Sabaratnam R, Gatter K. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology 2003; 42: 605-609.
20. Hausermann P, Khanna N, Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation. Dermatology 2004; 208: 287-290.
21. Schichman SA, McClure R, Schaefer RF, Mehta P. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol 2004; 77: 291-295.
22. Ojanguren J, Collazos J, Martinez C, Alvarez J, Mayo J. Epstein-Barr virus-related plasmablastic lymphomas arising from long-standing sacrococcygeal cysts in immunosuppressed patients. AIDS 2003; 17: 1582-1584.
23. Boluda S, Barranco C, Pijuan L, et al. KSHV-positive lymphoid skin infiltrate mimicking plasmablastic lymphoma in an HIV-infected patient. Mod Pathol 2004; 17 (supplement 1): 90A (abstract 368).
24. Cattaneo C, Facchetti F, Re A, et al. Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma 2005; 46: 77-81.
25. Teruya-Feldstein J, Chiao E, et al. CD2O-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004; 15: 1673-1679.
26. Jung CP, Horster S, Lohse P, Bogner JR, Emmerich B, Goebel FD. Uncommon hematologic malignancies. Case 1. Plasmablastic leukemia in HIV-associated multicentric Castleman's disease. J Clin Oncol 2003; 21: 4248-4249.
27. Laster R, Li C, Galbraith P, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 2004; 45: 1881-1885.
28. Lin O, Gerhard R, Zerbini MC, Teruya-Feldstein J. Cytologic features of plasmablastic lymphoma. Cancer. 2005; 105: 139-44.
29. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004; 28: 736-747.
30. Dezube BJ, Aboulafia DM, Pantanowitz L. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma. AIDS Read 2004; 14: 372-379.
31. Pantanowitz L, Beckwith B, Dezube BJ. HIV-associated plasma cell neoplasia. HIV & AIDS Review 2004; 3: 47-50.
32. Stewart JM, Krishnamurthy S. Fine-needle aspiration cytology of a case of HIV-associated anaplastic myeloma. Diagn Cytopathol 2002; 27: 218-222.
33. Vega F, Chang CC, Medeiros U, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005; 18: 806-15.
34. Brown RSD, Power DA, Spittle HF, Lankester KJ. Absence of immunohistochemical evidence for Human Herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man. Clinical Oncology 2000; 12: 194-196.
35. Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004; 28: 41-46.
36. Carbone A, Gloghini A, Gaidano G. Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004; 28: 1538-1540.
37. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95: 1406-1412.
38. Du MQ, Liu H, Diss TC, et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001; 97: 2130-2136.
39. Mate JL, Navarro JT, Ariza A, et al. Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma. Hum Pathol 2004; 35: 632-635.
40. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645-656.
41. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996; 105: 221-229.
42. Ely SA, Powers J, Lewis D, et al. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma arising in the subarachnoid space. Hum Pathol 1999; 30: 981-984.
43. Simonelli C, Spina M, Cinelli R, et al. Clinical Features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol 2003; 21: 3948-3954.
44. Ioakim-Liossi A, Mikou P, Botsoli-Stergiou F, et al. Primary effusion lymphoma. A case report. Acta Cytol 2004; 48: 269-272.
45. Said JW, Shintaku IP, Asou H, et al. Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Arch Path Lab Med 1999; 123: 257-260.
46. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-1191.
47. Horenstein MG, Nador RG, Chadburn A, et al. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997; 90: 1186-1191.
48. Callahan J, Pai S, Cotter M, Robertson ES. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Virology 1999; 262: 18-30.
49. Mikala G, Xie J, Berencsi G, et al. Human herpesvirus 8 in hematologic diseases. Pathol Oncol Res 1999; 5: 73-79.
50. Hamoudi R, Diss TC, Oksenhendler E, et al. Distinct cellular origins of primary effusion lymphoma with and without EBV infection. Leuk Res 2004; 28: 333-338.
51. Klein U, Gloghini A, Gaidano G, et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Mod Pathol 2002; 15: 1273-1278.
52. Costes V, Faumont N, Cesarman E, et al. Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma. Hum Pathol 2002; 33: 846-849.
53. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 2004; 28: 1401-1416.
54. Huang Q, Chang KL, Gaal KK, Weiss LM. KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphoma. Am J Surg Pathol 2004; 28: 693-697.
55. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002; 99: 2331-2336.
56. Katano H, Suda T, Morishita Y, et al. Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology. Mod Pathol 2000; 13: 77-85.
57. Navarro JT, Ribera JM, Junca J, Milla F. Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient. Hum Pathol 2003; 34: 630.
58. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn 2005; 7: 17-27.
59. Coupland SE, Charlotte F, Mansour G, Maloum K, Hummel M, Stein H. HHV-8 associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man. Am J Surg Pathol 2005; 29: 647-52.
60. DePond W, Said JW, Tasaka T, et al. Kaposi's sarcoma-associated herpes virus and human herpes virus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol 1997; 21: 719-724.
61. McGrath MS, Shiramizu B, Meeker TC, et al. AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process. J Acquir Immune Defic Syndr 1991; 4: 408-415.
62. Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol 2003; 27: 293-302.
63. Fan W, Bubman D, Chadburn A, Harrington WJ Jr, Cesarman E, Knowles DM. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol 2005; 79: 1244-1251.
64. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996; 88: 264826-54.
65. Carbone A, Cilia AM, Gloghini A, et al. Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma. Leukemia 2000; 14: 1301-1309.